Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Single Dose, Two Treatment, Two Period Crossover Pharmacokinetic Study Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®) in Healthy Volunteers
Conditions
Interventions
Menthae piperitae aetheroleum/peppermint oil (enteric coated capsule)
Menthae piperitae aetheroleum/peppermint oil (colon-targeted-delivery capsule)
Locations
1
Netherlands
Maastricht University Medical Center
Maastricht, Limburg, Netherlands
Start Date
March 1, 2015
Primary Completion Date
July 1, 2015
Completion Date
September 1, 2015
Last Updated
January 24, 2022
NCT07481422
NCT05740319
NCT07089420
NCT06866106
NCT05293769
NCT03823742
Lead Sponsor
Maastricht University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions